Adenovirus-vectored vaccine(Walvax Biotechnology)

N/A

Report date: 2024/07/23 17:55:26

Base Information

Drug NameAdenovirus-vectored vaccine(Walvax Biotechnology)
Drug Alias NameChAdTS-S
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vectorVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesWalvax Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWalvax Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A